MODALITY
saveAntisense Oligonucleotide (ASO)
Short synthetic oligonucleotides modulating RNA.
also known as: aso, antisense
🐶 often sniffed alongside
top 1drugs
0
catalysts
0
news
194
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- nChroma halves headcount, calls time on trial of potential HBV ‘cure’fiercebiotech · 16h ago
- CTAD 2026: Biogen, AriBio lead the way in slowing cognitive decline in Alzheimer’sbiospace · 1d ago
- Biogen’s tau therapy drives bigger benefits in 2-year Alzheimer’s updatefiercebiotech · 1d ago
- Alzheimer’s field looks beyond amyloid as biopharma converges at CTAD 2026biospace · 3d ago
- Deep dive: Cardiovascular calamities and catalystsbiospace · 7d ago
- Details from Novartis’ failed cardiovascular trial offer ‘little silver lining’ for rivalsbiospace · 10d ago
- AHA: Novartis’ Lp(a) drug shows zero benefit, casting shadow over Amgen and Lilly programsfiercebiotech · 14d ago
- Biogen set up for growth even without M&A but CEO won’t rule it outbiospace · 22d ago
Data sources
last refreshed 8m ago
Found something off?
comments(0)
5-min edit window · permanent after that